Moreover, protective effects of GHR deficiency against tumors and diabetes can be evaluated by crossing the GHR KO mutation in existing pig models that are genetically predisposed to tumor development (e.g., [86]) or (pre-)diabetes [27], [87], thus bridging the gap between rodents and humans in longevity research with tailored large animal models. Here, GHR is linked to neoplasm.